Literature DB >> 2285754

Self-reported fatigue in rheumatoid arthritis. A pilot study.

B B Tack.   

Abstract

The purpose of this pilot study was to examine the symptom of fatigue in rheumatoid arthritis. The instruments used included the Profile of Mood States, fatigue and pain visual analog scales, and an interviewer's assessment of respondent fatigue. The results indicated that fatigue was a significant problem in this sample; fatigue was positively associated with depression, pain, and poorer overall mood state; and the three measures of fatigue produced congruent reports of fatigue.

Entities:  

Mesh：

Year:  1990        PMID： 2285754

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN： 0893-7524


  19 in total

1.  A multidimensional model of fatigue in patients with rheumatoid arthritis.

Authors:  Perry M Nicassio; Sarah R Ormseth; Mara K Custodio; Michael R Irwin; Richard Olmstead; Michael H Weisman
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

Review 2.  Certolizumab pegol: a new biologic targeting rheumatoid arthritis.

Authors:  Aarat M Patel; Larry W Moreland
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

3.  Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.

Authors:  Johanna M Hazes; Peter Taylor; Vibeke Strand; Oana Purcaru; Geoffroy Coteur; Philip Mease
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

4.  Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis.

Authors:  Jacques Pouchot; Raheem B Kherani; Rollin Brant; Diane Lacaille; Allen J Lehman; Stephanie Ensworth; Jacek Kopec; John M Esdaile; Matthew H Liang
Journal:  J Clin Epidemiol       Date:  2008-03-21       Impact factor: 6.437

5.  Fatigue with systolic heart failure.

Authors:  Anne M Fink; Shawna L Sullivan; Julie J Zerwic; Mariann R Piano
Journal:  J Cardiovasc Nurs       Date:  2009 Sep-Oct       Impact factor: 2.083

6.  Fatigue: an overlooked determinant of physical function in scleroderma.

Authors:  S B Sandusky; L McGuire; M T Smith; F M Wigley; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-12-23       Impact factor: 7.580

7.  The moderating role of personal mastery on the relationship between caregiving status and multiple dimensions of fatigue.

Authors:  Susan K Roepke; Brent T Mausbach; Roland von Känel; Sonia Ancoli-Israel; Alexandrea L Harmell; Joel E Dimsdale; Kirstin Aschbacher; Paul J Mills; Thomas L Patterson; Igor Grant
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

8.  Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.

Authors:  Sang-Cheol Bae; Suk Chyn Gun; Chi Chiu Mok; Rezaul Khandker; Henk W Nab; Andrew S Koenig; Bonnie Vlahos; Ron Pedersen; Amitabh Singh
Journal:  BMC Musculoskelet Disord       Date:  2013-01-08       Impact factor: 2.362

9.  Long-term health-enhancing physical activity in rheumatoid arthritis--the PARA 2010 study.

Authors:  Birgitta Nordgren; Cecilia Fridén; Ingrid Demmelmaier; Gunnar Bergström; Christina H Opava
Journal:  BMC Public Health       Date:  2012-06-01       Impact factor: 3.295

Review 10.  Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety.

Authors:  Philip J Mease
Journal:  Rheumatology (Oxford)       Date:  2010-09-25       Impact factor: 7.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.